This is of interest to AD research because inhibition of PDE4 is known to reverse Aβ-induced memory deficits [43]; PDE5 inhibition is known to ameliorate synaptic sprouting [44] and axonal remodelling [45] and PDE3 inhibition is known to enhance neurogenesis [46]. The gene discussed is PDE5A; the disease is Alzheimer disease.